| -Stumbling blocks in weight reduction--new genetic and metabolic hindrances in weight reduction-. MA Nauck, WH Schmiegel Zeitschrift fur Gastroenterologie 34 (3), 207-209, 1996 | | 1996 |
| " Resistin": Ein neuentdecktes Hormon aus dem Fettgewebe, das die Insulinresistenz und damit Stoffwechselerkrankungen bei Adipositas erklären könnte CM Steppan, ST Bailey, S Bhat, EJ Brown, RR Banerjee, CM Wright, ... Diabetes und Stoffwechsel 10 (2), 87-89, 2001 | | 2001 |
| „Feed-Back “-Suppression der Nahrungs-induzierten GLP-1-Sekretion durch Erhöhung des intakten GLP-1 unter DPP-4-Inhibition: Ein Vergleich von Vildagliptin und Sitagliptin O Baranov, CF Deacon, JJ Holst, K Preuss, MA Nauck Diabetologie und Stoffwechsel 9 (S 01), P270, 2014 | | 2014 |
| „Glucose-depedent Insulinotropic Polypeptide “(GIP) verstärkt die antidiabetischen Wirkungen von N Mentis, LD Köthe, J Holst, C Deacon, VWS Ng, M Theodorakis, ... Diabetologie und Stoffwechsel 4 (S 01), FV_61, 2009 | | 2009 |
| 1. T2DM: an introduction E Ferrannini, M Nauck The significance of the kidney in diabetes, 4, 2012 | | 2012 |
| 1.6 Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less … M Diamant, M Nauck, R Shaginian, J Malone, S Cleall, D de Vries, ... Nederlands Tijdschrift voor Diabetologie 11, 79-79, 2013 | | 2013 |
| 1.7 Efficacy and Safety of Dulaglutide vs. Sitagliptin after 52 Weeks in Type 2 diabetes (AWARD-5)(71-OR) MA Nauck, RS Weinstock, GE Umpierrez, B Guerci, KL Boleyn, ... Nederlands Tijdschrift voor Diabetologie 11, 79-80, 2013 | | 2013 |
| 26.3 Hyperglykämische Entgleisungen (Diabetisches» Koma «)–394 HG Joost, M Nauck Pharmakotherapie, 387, 0 | | |
| 342-P: Effects of Sitagliptin on Hypoglycemic Episodes and Counterregulation in Type 2 Diabetic Patients Tightly Titrated with Insulin Glargine MA Nauck, A Feldmann, JJ Meier, M Nauck, C Kapitza Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 35th Annual Meeting of the European Association for the Study of Diabetes: Brussels, Belgium, 28 September-2 October 1999. A Melander, J Olsson, G Lindberg, A Salzman, T Howard, P Stang, ... Diabetologia 42 (Suppl 1), A1-A330, 1999 | 9 | 1999 |
| 36. EASD Annual Meeting of the European Association for the Study of Diabetes M Nauck, T Heise, L Heinemann, J Meier DIABETES UND STOFFWECHSEL 9 (6), 353-358, 2000 | | 2000 |
| 3909 Risk of major cardiovascular events in patients with type 2 diabetes with and without prior cardiovascular events: results from the LEADER trial NR Poulter, SC Bain, JB Buse, T Monk-Hansen, M Nauck, S Rasmussen, ... European Heart Journal 38 (suppl_1), ehx504. 3909, 2017 | | 2017 |
| 4. DPP-4 inhibitors in general and linagliptin in particular as a new treatment option in T2DM T Hach, M Nauck The significance of the kidney in diabetes, 56, 2012 | | 2012 |
| 40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5-9 September 2004. M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ... Diabetologia 47 (Suppl 1), A1-A464, 2004 | 51 | 2004 |
| 46-jähriger Patient mit Hypoglykämie nach Krampfanfall I Vardarli, A Fenske, MA Nauck, E Jäckel, H Leitolf DMW-Deutsche Medizinische Wochenschrift 135 (18), 913-914, 2010 | | 2010 |
| 46-year-old man with hypoglykemia after seizure I Vardarli, A Fenske, MA Nauck, E Jäckel, H Leitolf Deutsche medizinische Wochenschrift 135 (18), 913-914, 2010 | | 2010 |
| 55-OR: Oral Semaglutide vs. Liraglutide and Placebo in T2D: PIONEER 4 RE Pratley, A Amod, ST Hoff, T Kadowaki, I Lingvay, MA Nauck, ... Diabetes 68 (Supplement 1), 2019 | 1 | 2019 |
| 58-OR: The novel dual GIP and GLP-1 receptor agonist tirzepatide transiently delays gastric emptying similarly to a selective long-acting GLP-1 receptor agonist S Urva, MA Nauck, T Coskun, X Cui, A Haupt, C Benson, C Loghin Diabetes 68 (Supplement 1), 2019 | 2 | 2019 |
| 61. Jahrestagung der Amerikanischen Diabetesgesellschaft (ADA) v. 22.-26. Juni 2001 in Philadelphia, USA B Willms, MA Nauck, A Lueg, M Hummel, U Schnell, M Fuchtenbusch DIABETES UND STOFFWECHSEL 10 (4), 183-192, 2001 | | 2001 |
| 8 weeks treatment with RI 583, a novel long-acting, human GLP-1 analogue improves beta cell function in metformin-treated diabetic subjects: a double-blind, placebo-controlled … R Berria, A Gastaldelli, M Nauck, M Boldrin, V Asnaghi, R Balena Diabetologia 51, S347-S348, 2008 | 2 | 2008 |
Jens Juul HolstProfessor of Medical Physiology, University of Copenhagen在 sund.ku.dk 的电子邮件经过验证
